Wednesday, June 10, 2026

pharma Β· Dravet syndrome Β· Primary Hyperoxaluria (PH) of all subtypes (PH1, PH2 and PH3)

Biocodex

Biocodex trial registry β€” 5 ClinicalTrials.gov studies with program phase, status, and indication context.

Gentilly, FR HQ
1953 Founded
1,648 Employees
EMA registrant Type
Company details
Status
Public
HQ
Gentilly, FR
Founded
1953
Employees
1,648
Programs
5
Drugs
15
Patents
25
Intelligence Β· Clinical Trials

Biocodex clinical trials

Registry index of 5 ClinicalTrials.gov studies linked to Biocodex programs β€” each row shows trial ID, program name, phase, status, and indication.

Biocodex trial registry β€” 5 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

5 updates

Latest clinical program signals indexed for Biocodex.

  1. STP226 β€” Phase 3

    Clinical update
  2. Sb 241 β€” Approved

    Clinical update
  3. STP237 β€” Phase 1

    Clinical update
  4. STP218 β€” Phase 1

    Clinical update
  5. BoWell - Sb252 β€” Phase 3

    Clinical update

Trial registry

5 studies
  1. 2023-508694-80-01

    Sb 241

    Approved active small_molecule

    Patients undergoing antibiotic therapy (in the context of erythema migrans (early skin form of Lyme borreliosis))

    CTIS β†—